Reporter gene imaging "visualized" the integration of two growing technologies: CRISPR/Cas9-based genome editing and induced pluripotent stem cell therapy.
European journal of nuclear medicine and molecular imaging, 48(3): 664-665 PMID 33215320 DOI 10.1007/s00259-020-05117-x
Abstract
This article has no abstract in PubMed.